NIH-funded research R21 grant

Understanding the genetics behind substance use disorders

Official title: Finding the missing parts of human genetics of substance use disorders

Funded at Yale University · NIH-11168362 · Data updated 2026-11-12

This study is looking at how our genes might influence substance use disorders, with the hope of finding new ways to help people struggling with addiction by using advanced genetic testing.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJune 1, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$357,613
NIH project number1R21DA063120-01
Project IDNIH-11168362 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of substance use disorders, including alcohol and cannabis use disorders.

Less likely to help

Patients who do not have a history of substance use disorders or those with other unrelated health conditions may not benefit from this research.

What this research studies

This research investigates the genetic factors that contribute to substance use disorders (SUDs), which are significant causes of death and disability. By utilizing whole-genome sequencing (WGS) data from biobanks, the study aims to identify both common and rare genetic variants associated with SUDs. This approach seeks to fill gaps left by previous studies that primarily focused on common variants, thereby enhancing the understanding of genetic risk factors. The ultimate goal is to improve diagnosis, prevention, and treatment strategies for individuals affected by addiction.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment options for individuals with substance use disorders.

How similar studies have gone: Previous research using whole-genome sequencing has shown promise in uncovering genetic factors for various conditions, suggesting potential success for this novel approach in substance use disorders.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Zhou, Hang — Yale University
  • Study coordinator: Zhou, Hang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.